Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Open Access
- 1 June 1984
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 159 (6), 1669-1685
- https://doi.org/10.1084/jem.159.6.1669
Abstract
The complment fragments C3b [complement component 3b] and C4b are the main ligands for the membrane receptor CR1. CR1 functions as an essential cofactor for the factor I-mediated enzymatic breakdown of membrane-bound C3b (*C3b) into C3c and *C3dg. CR1 also promotes the degradation of bound C4b (*C4b) into C4c and *C4d. On a weight basis, the cofactor activity of CR1 in the cleavage of *C4b present on the cell intermediate EAC14 [antibody sensitized sheep erythrocyte bound to complement C1 and C4] is 103-fold greater than that of the serum cofactor C4-binding protein (C4bp). The effect of CR1 on either *C3b or *C4b is modulated by the presence of the other ligand in its vicinity; that is, *C4b degradation by CR1 plus I is enhanced by neighboring *C3b and vice versa. Upon uptake of optimal amounts of *C3b onto EAC142 and the assembly of the C3-convertase EAC1423, the activity of CR1 in generating C4c is enhanced 5-10 times further. When the number of *C3b molecules on EAC1423 is relatively small (or when EAC1423 had been converted by I plus H into EAC1423i), the presence of neighboring *C4b enhances the conversion of *C3b (or *iC3b) into C3c plus *C3dg. The enhancing effect of *C3b on the cleavage of *C4b by I is observed only if the cofactor of this reaction is CR1. The activity of I or I plus C4bp on *C4b is significantly inhibited when *C3b is fixed and the main product of the reaction is *iC4b. Degradation of *C4b will be more effecive when enough C3b molecules are fixed nearby, thus facilitating the interaction of *C4b*3b clusters with CR1-bearing cells, and that under physiological conditions. *C4b activity can be efficiently controlled by CR1.This publication has 29 references indexed in Scilit:
- Complement receptor is an inhibitor of the complement cascade.The Journal of Experimental Medicine, 1981
- Purification of the human complement control protein C3b inactivatorBiochemical Journal, 1980
- Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.The Journal of Immunology, 1980
- Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.Proceedings of the National Academy of Sciences, 1979
- Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membraneProceedings of the National Academy of Sciences, 1979
- The role of C4-binding protein and {beta }1H in proteolysis of C4b and C3bThe Journal of Experimental Medicine, 1979
- The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytesBiochemical Journal, 1978
- C3-mediated cytoadherence. Formation of C3 receptor aggregates as prerequisite for cell attachment.The Journal of Experimental Medicine, 1975
- THE REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSISThe Journal of Experimental Medicine, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970